CRISPR THERAPEUTICS AG earnings per share and revenue

CRSP/N earnings per share for the last quarter are -27.33 MXN whereas the estimation was -26.18 MXN which accounts for -4.38% surprise. Company revenue for the same period amounts to 9.48 M MXN despite the estimated figure of 221.12 M MXN. Estimated earnings per share for the next quarter are -28.07 MXN, and revenue is expected to reach 130.93 M MXN. Also watch annual changes over time to get a bigger picture of CRSP/N earnings per share and revenue dynamics.